Kingworld Medicines Group Limited (HKG:1110)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.465
0.00 (0.00%)
Apr 29, 2026, 3:58 PM HKT
-16.96%
Market Cap 275.50M
Revenue (ttm) 1.02B
Net Income (ttm) 12.55M
Shares Out 592.46M
EPS (ttm) 0.02
PE Ratio 21.71
Forward PE n/a
Dividend 0.03 (6.60%)
Ex-Dividend Date Jun 5, 2025
Volume 1,532,000
Average Volume 1,276,200
Open 0.455
Previous Close 0.465
Day's Range 0.440 - 0.465
52-Week Range 0.420 - 0.780
Beta 0.92
RSI 40.94
Earnings Date Mar 31, 2026

About Kingworld Medicines Group

Kingworld Medicines Group Limited, an investment holding company, primarily engages in the distribution and sale of branded imported pharmaceutical and healthcare products. The company offers products for relieving cough, alleviating phlegm, soothing asthma, enhancing respiratory system, aiding digestion, promoting intestinal health, activating blood circulation, relieving pain, combating flu, and other categories under the Nin Jiom Chuan Bei Pei Pa Koa, Taiko Seirogan, Kingworld Imada Red Flower Oil, Culturelle probiotics product series brands... [Read more]

Sector Healthcare
Founded 1996
Employees 759
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 1110
Full Company Profile

Financial Performance

In 2025, Kingworld Medicines Group's revenue was 917.34 million, a decrease of -13.55% compared to the previous year's 1.06 billion. Earnings were 11.28 million, a decrease of -72.85%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.